James Clavijo joined Longeveron in 2019. He has over 25 years of experience in executive, finance and accounting activities, including experience as a Chief Financial Officer for several pharmaceutical, healthcare, medical device and manufacturing companies. Mr. Clavijo’s experience has included building, leading and advising companies with strategic plans for pharmaceutical commercialization and manufacturing, negotiating licensing and drug development agreements, as well as advising companies with complex restructurings, mergers and acquisitions, capital market transactions, and system implementations. During 2018, Mr. Clavijo served as the Chief Financial Officer for Aeterna Zentaris (NASDAQ: AEZS). Prior to this, Mr. Clavijo served for two years as the Chief Financial Officer for Tri-source Pharma, a pharmaceutical company focused on procuring pharmaceutical products facing supply issues and supplying pharmaceutical products to veterinary markets. Since 2009, Mr. Clavijo, has also served as founder and principal of Barcelona Capital Partners, a consulting firm that provided Chief Financial Officer services, that includes the preparation of regulatory filings with the Securities and Exchange Commission. Previously, Mr. Clavijo served for five years as the Chief Accounting Officer at Soligenix (NASDAQ: SNGX), a public biopharmaceutical company. In addition, Mr. Clavijo worked for Deloitte & Touche and was an Officer in the U.S. Army, serving for 13 years in active and reserve duty. Mr. Clavijo was licensed as a CPA in Florida from 2000-2011. He was licensed in Florida as a real estate/business agent since 2013-2021. Mr. Clavijo received a BA in Chemistry (PreMed) from the University of Florida, a BA in Accounting from the University of Nebraska, and a Masters in Accounting from Florida International University.
What is James Clavijo's net worth?
The estimated net worth of James Clavijo is at least $11,531.73 as of June 27th, 2023. Mr. Clavijo owns 6,230 shares of Longeveron stock worth more than $11,532 as of November 21st. This net worth estimate does not reflect any other assets that Mr. Clavijo may own. Learn More about James Clavijo's net worth.
How do I contact James Clavijo?
Has James Clavijo been buying or selling shares of Longeveron?
James Clavijo has not been actively trading shares of Longeveron during the last ninety days. Most recently, James Clavijo sold 500 shares of the business's stock in a transaction on Thursday, June 29th. The shares were sold at an average price of $35.10, for a transaction totalling $17,550.00. Following the completion of the sale, the chief financial officer now directly owns 4,730 shares of the company's stock, valued at $166,023. Learn More on James Clavijo's trading history.
Who are Longeveron's active insiders?
Are insiders buying or selling shares of Longeveron?
During the last year, Longeveron insiders bought shares 5 times. They purchased a total of 150,436 shares worth more than $370,049.60. The most recent insider tranaction occured on April, 11th when CEO Mohamed Wa'el Ahmed Hashad bought 10,638 shares worth more than $24,999.30. Insiders at Longeveron own 19.1% of the company.
Learn More about insider trades at Longeveron. Information on this page was last updated on 4/11/2024.
